EP2590623A1 - Malvidin for promoting hair growth - Google Patents
Malvidin for promoting hair growthInfo
- Publication number
- EP2590623A1 EP2590623A1 EP11728886.0A EP11728886A EP2590623A1 EP 2590623 A1 EP2590623 A1 EP 2590623A1 EP 11728886 A EP11728886 A EP 11728886A EP 2590623 A1 EP2590623 A1 EP 2590623A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- hair
- malvidin
- care composition
- derivative
- hair care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 title claims abstract description 65
- 235000009584 malvidin Nutrition 0.000 title claims abstract description 32
- 230000003779 hair growth Effects 0.000 title claims abstract description 12
- 230000001737 promoting effect Effects 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 78
- 210000004209 hair Anatomy 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 28
- 201000004384 Alopecia Diseases 0.000 claims abstract description 19
- 239000002537 cosmetic Substances 0.000 claims abstract description 14
- 208000024963 hair loss Diseases 0.000 claims abstract description 11
- 230000003676 hair loss Effects 0.000 claims abstract description 11
- 239000000835 fiber Substances 0.000 claims abstract description 8
- 230000001965 increasing effect Effects 0.000 claims abstract description 8
- 230000004936 stimulating effect Effects 0.000 claims abstract description 8
- 230000003698 anagen phase Effects 0.000 claims abstract description 6
- 231100000360 alopecia Toxicity 0.000 claims abstract description 4
- 239000004094 surface-active agent Substances 0.000 claims description 25
- 239000003093 cationic surfactant Substances 0.000 claims description 20
- 239000002453 shampoo Substances 0.000 claims description 17
- 210000004761 scalp Anatomy 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 229920001296 polysiloxane Polymers 0.000 claims description 10
- 239000002280 amphoteric surfactant Substances 0.000 claims description 6
- 239000000375 suspending agent Substances 0.000 claims description 5
- 208000001840 Dandruff Diseases 0.000 claims description 4
- 240000006365 Vitis vinifera Species 0.000 claims description 4
- 239000003945 anionic surfactant Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 241000195940 Bryophyta Species 0.000 claims description 3
- 235000006770 Malva sylvestris Nutrition 0.000 claims description 3
- 240000002129 Malva sylvestris Species 0.000 claims description 3
- 241001085296 Primula x polyantha Species 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- 235000011929 mousse Nutrition 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000006286 aqueous extract Substances 0.000 claims description 2
- 208000004631 alopecia areata Diseases 0.000 abstract description 3
- 208000019901 Anxiety disease Diseases 0.000 abstract description 2
- 206010041250 Social phobia Diseases 0.000 abstract description 2
- 206010068168 androgenetic alopecia Diseases 0.000 abstract description 2
- 230000036506 anxiety Effects 0.000 abstract description 2
- 230000003721 exogen phase Effects 0.000 abstract description 2
- 230000009583 hair follicle growth Effects 0.000 abstract description 2
- 230000003797 telogen phase Effects 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract 1
- -1 conditioners Substances 0.000 description 20
- 230000003750 conditioning effect Effects 0.000 description 16
- 125000000217 alkyl group Chemical group 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 13
- 229920000642 polymer Polymers 0.000 description 13
- 150000002191 fatty alcohols Chemical class 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229960003632 minoxidil Drugs 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 102000004257 Potassium Channel Human genes 0.000 description 7
- 125000000129 anionic group Chemical group 0.000 description 7
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- 108020001213 potassium channel Proteins 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 125000002252 acyl group Chemical group 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 229920006317 cationic polymer Polymers 0.000 description 4
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 239000002888 zwitterionic surfactant Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 230000002297 mitogenic effect Effects 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- QTDIEDOANJISNP-UHFFFAOYSA-N 2-dodecoxyethyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOCCOS(O)(=O)=O QTDIEDOANJISNP-UHFFFAOYSA-N 0.000 description 2
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020864 Hypertrichosis Diseases 0.000 description 2
- YYVIFBVXJYYHCW-UHFFFAOYSA-N Malvin Natural products COc1cc(cc(OC)c1O)C2=C(Cc3c(OC4OC(CO)C(O)C(O)C4O)cc(O)cc3O2)OC5OC(CO)C(O)C(O)C5O YYVIFBVXJYYHCW-UHFFFAOYSA-N 0.000 description 2
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229940127315 Potassium Channel Openers Drugs 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- TTZLKXKJIMOHHG-UHFFFAOYSA-M benzyl-decyl-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 TTZLKXKJIMOHHG-UHFFFAOYSA-M 0.000 description 2
- PXFDQFDPXWHEEP-UHFFFAOYSA-M benzyl-dimethyl-octylazanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)CC1=CC=CC=C1 PXFDQFDPXWHEEP-UHFFFAOYSA-M 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- WLCFKPHMRNPAFZ-UHFFFAOYSA-M didodecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC WLCFKPHMRNPAFZ-UHFFFAOYSA-M 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 2
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- CILLXFBAACIQNS-BTXJZROQSA-O malvin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC(O)=CC=3[O+]=2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 CILLXFBAACIQNS-BTXJZROQSA-O 0.000 description 2
- 229940117886 malvin Drugs 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- FCTRVTQZOUKUIV-MCDZGGTQSA-M potassium;[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound [K+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)([O-])=O)[C@@H](O)[C@H]1O FCTRVTQZOUKUIV-MCDZGGTQSA-M 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 229940032044 quaternium-18 Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 2
- AQZSPJRLCJSOED-UHFFFAOYSA-M trimethyl(octyl)azanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)C AQZSPJRLCJSOED-UHFFFAOYSA-M 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LPJKDVHMUUZHRY-KVVVOXFISA-N (z)-octadec-9-en-1-amine;hydrochloride Chemical compound Cl.CCCCCCCC\C=C/CCCCCCCCN LPJKDVHMUUZHRY-KVVVOXFISA-N 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical group C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- UDJZTGMLYITLIQ-UHFFFAOYSA-N 1-ethenylpyrrolidine Chemical compound C=CN1CCCC1 UDJZTGMLYITLIQ-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- FSAMVJAGJWGWTQ-UHFFFAOYSA-N 2-hexadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCOCCO FSAMVJAGJWGWTQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- KQIKOUUKQBTQBE-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-1lambda^{4}-chromen-1-ylium chloride Chemical compound [Cl-].COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KQIKOUUKQBTQBE-UHFFFAOYSA-N 0.000 description 1
- KSLINXQJWRKPET-UHFFFAOYSA-N 3-ethenyloxepan-2-one Chemical compound C=CC1CCCCOC1=O KSLINXQJWRKPET-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- VKELSQNRSVJHGR-UHFFFAOYSA-N 4-oxo-4-sulfooxybutanoic acid Chemical compound OC(=O)CCC(=O)OS(O)(=O)=O VKELSQNRSVJHGR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920013683 Celanese Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- DLELFDUXILGOPM-SFHVURJKSA-N Glabranin Natural products CC(C)C=Cc1c(O)cc(O)c2C(=O)C[C@H](Oc12)c3ccccc3 DLELFDUXILGOPM-SFHVURJKSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000382417 Malva Species 0.000 description 1
- 235000013939 Malva Nutrition 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- YDIKCZBMBPOGFT-PWUSVEHZSA-N Malvidin 3-galactoside Chemical compound [Cl-].COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)=C1 YDIKCZBMBPOGFT-PWUSVEHZSA-N 0.000 description 1
- PXUQTDZNOHRWLI-JJYSZZJESA-O Oenin Natural products O(C)c1c(O)c(OC)cc(-c2c(O[C@H]3[C@@H](O)[C@H](O)[C@H](O)[C@@H](CO)O3)cc3c(O)cc(O)cc3[o+]2)c1 PXUQTDZNOHRWLI-JJYSZZJESA-O 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000016816 Pisum sativum subsp sativum Nutrition 0.000 description 1
- 241000245063 Primula Species 0.000 description 1
- 235000000497 Primula Nutrition 0.000 description 1
- PXUQTDZNOHRWLI-QOPOCTTISA-O Primulin Natural products O(C)c1c(O)c(OC)cc(-c2c(O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O3)cc3c(O)cc(O)cc3[o+]2)c1 PXUQTDZNOHRWLI-QOPOCTTISA-O 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- 235000005318 Serenoa repens Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000009467 Sulphonylurea receptors Human genes 0.000 description 1
- 108050000353 Sulphonylurea receptors Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- ZWXYEWJNBYQXLK-UHFFFAOYSA-N azanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O ZWXYEWJNBYQXLK-UHFFFAOYSA-N 0.000 description 1
- 229940075506 behentrimonium chloride Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000005774 blackeyed pea Nutrition 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 231100001012 cardiac lesion Toxicity 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229960004042 diazoxide Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- DAWSYIQAGQMLFS-SFHVURJKSA-N glabranin Chemical compound C1([C@@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)CC=C(C)C)=CC=CC=C1 DAWSYIQAGQMLFS-SFHVURJKSA-N 0.000 description 1
- OOKJEMBYFZCLNC-UHFFFAOYSA-N glabranin Natural products O1C(C(O)CCC(O)C(O)CCC=CCCCCCCCCCC)CCC1CCCCCCCC(O)CC1=CC(C)OC1=O OOKJEMBYFZCLNC-UHFFFAOYSA-N 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003695 hair diameter Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 125000000346 malonyl group Chemical group C(CC(=O)*)(=O)* 0.000 description 1
- PXUQTDZNOHRWLI-OXUVVOBNSA-O malvidin 3-O-beta-D-glucoside Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 PXUQTDZNOHRWLI-OXUVVOBNSA-O 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 235000019508 mustard seed Nutrition 0.000 description 1
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
- KHPAAXRLVYMUHU-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CC KHPAAXRLVYMUHU-UHFFFAOYSA-N 0.000 description 1
- KKBOOQDFOWZSDC-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CC KKBOOQDFOWZSDC-UHFFFAOYSA-N 0.000 description 1
- NCBXVQKSCKRNTB-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]icosanamide Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)NCCN(C)C NCBXVQKSCKRNTB-UHFFFAOYSA-N 0.000 description 1
- XNJXGLWSAVUJRR-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCN(C)C XNJXGLWSAVUJRR-UHFFFAOYSA-N 0.000 description 1
- DYAVLIWAWOZKBI-UHFFFAOYSA-N n-[3-(diethylamino)propyl]hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCCN(CC)CC DYAVLIWAWOZKBI-UHFFFAOYSA-N 0.000 description 1
- OVCKOYOTKXBZKK-UHFFFAOYSA-N n-[3-(diethylamino)propyl]icosanamide Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)NCCCN(CC)CC OVCKOYOTKXBZKK-UHFFFAOYSA-N 0.000 description 1
- KUIOQEAUQATWEY-UHFFFAOYSA-N n-[3-(diethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(CC)CC KUIOQEAUQATWEY-UHFFFAOYSA-N 0.000 description 1
- MNAZHGAWPCLLGX-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C MNAZHGAWPCLLGX-UHFFFAOYSA-N 0.000 description 1
- BDHJUCZXTYXGCZ-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCCN(C)C BDHJUCZXTYXGCZ-UHFFFAOYSA-N 0.000 description 1
- HJXPIPGLPXVLGN-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]icosanamide Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C HJXPIPGLPXVLGN-UHFFFAOYSA-N 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- VXAPDXVBDZRZKP-UHFFFAOYSA-N nitric acid phosphoric acid Chemical compound O[N+]([O-])=O.OP(O)(O)=O VXAPDXVBDZRZKP-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003450 potassium channel blocker Substances 0.000 description 1
- 239000004036 potassium channel stimulating agent Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000010018 saw palmetto extract Substances 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- 229940032160 stearamidoethyl diethylamine Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229960005371 tolbutamide Drugs 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 229940100613 topical solution Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Definitions
- This invention relates to a hair care composition comprising malvidin or a derivative thereof.
- the invention also relates to a cosmetic method for increasing hair fibre diameter, stimulating hair growth, retaining hair or reducing hair loss, stimulating hair follicle growth in anagen or telogen phases, increasing hair fibre density and preventing or treating alopecia.
- One of the major hair concerns for both men and women is that of hair loss.
- male pattern baldness known as alopecia areata.
- hair shedding resulting in hair thinning is also a concern for both men and women.
- Individuals suffering hair loss often experience psychological disadvantages, for example social phobia, anxiety, and depression, due to their change in appearance.
- Minoxidil was originally produced as an oral anti-hypertensive drug (LonitenTM), which was found to also have hypertrichosis effects.
- Messenger et al (Br. J. Dermatol., 150/2, 186-194 (2004)), showed in clinical trials that topical minoxidil increases hair growth and diameter, triggering anagen induction and prolonging length of anagen and hence hair.
- Sanders et al (J. Invest. Dermatol., 107/2, 229-234 (1996)) have shown that minoxidil is able to increase cell proliferation in NIH 3T3 fibroblasts via the opening of potassium channels.
- Messenger et al showed that other potassium channel openers exhibit a similar hypertrichosis effect.
- VEGF vascular endothelial growth factor
- minoxidil The side effects of minoxidil include itchy scalp and dandruff, often due to the alcohol required for its topical formulation.
- Side effects of oral minoxidil include swelling of the face and extremities, rapid and irregular heartbeat, lightheadedness and cardiac lesions.
- Herbal treatments with saw palmetto and green tea extracts (both of which comprise 5-alpha reductase inhibitors), and Gingko biloba extract (which comprises an active vasodilator) have been used.
- Non-invasive treatments include scalp massage with essential oils.
- Caffeine has also been identified as a stimulator of human hair growth in-vitro, and reduced testosterone-induced follicle growth suppression.
- a solution to the aforementioned problem of hair loss is provided in the form of a hair care composition
- a hair care composition comprising malvidin or a derivative thereof in a composition form selected from the group consisting of a shampoo, a conditioner, a spray, a mousse, a gel, an oil, a cream, a wax and a lotion.
- Malvidin is an O-methylated anthocyanidin of empirical chemical formula C17H15O7+ highly abundant in nature. It is primarily responsible for the color of red wine, Vitis vinifera being one of its sources. It is also one of the anthocyanidins responsible for the blue pigment found in the Primula polyanthus plant.
- the lUPAC name for malvidin is 3,5,7-trihydroxy-2-(4-hydroxy- 3,5-dimethoxyphenyl)chromenium and has the following chemical structure:
- the malvidin or a derivative thereof may be in the form of an aqueous extract of any one of the group consisting of a Vitis vinifera grape skin, a Primula polyanthus flower and a Malva sylvestris flower.
- the malvidin or a derivative thereof is in the weight range 0.00001 to 30 %, preferably 0.0001 to 15 %, most preferably 0.001 to 5 % by weight of the composition.
- Derivatives include glycosides such as glucosides or galactosides, acyl and malonyl derivatives. Specific derivatives are malvin, a diglucoside of malvidin, oenin, a 3- glucoside of malvidin found in the skin of purple grapes, and primulin, a 3- galactoside of malvidin. Malvin is found as a pigment in herbs like Malva (Malva sylvestris), Primula and Rhodoendron.
- a hair care composition comprising malvidin or a derivative thereof and an ingredient selected from the group consisting of a cationic surfactant, a fatty material, a suspending agent, a silicone, an anti-dandruff agent, an anionic surfactant, an amphoteric surfactant, a zwitlerionic surfactant and a fragrance.
- a cosmetic method for stimulating hair growth comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
- a cosmetic method for increasing hair fibre density comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
- a cosmetic method for increasing hair fibre diameter comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
- a cosmetic method for retaining hair or reducing hair loss is provided, the method the step of comprising applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
- a cosmetic method for preventing or treating alopecia comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
- a cosmetic method for stimulating anagen induction comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
- the final product form of the hair care compositions according to the invention may suitably be, for example, shampoos, conditioners, sprays, mousses, gels, oils, creams, waxes or lotions.
- Particularly preferred product forms are leave-in products, especially post-wash conditioners (leave-in) and hair treatment products such as hair essences.
- Conditioner compositions usually comprise one or more conditioning surfactants, which are cosmetically acceptable and suitable for topical application to the hair.
- Suitable conditioning surfactants are selected from cationic surfactants, used singly or in a mixture.
- Cationic surfactants useful in compositions of the invention contain amino or quaternary ammonium hydrophilic moieties, which are positively charged when, dissolved in the aqueous composition of the present invention.
- the most preferred cationic surfactants for conditioner compositions of the present invention are monoalkyl quaternary ammonium compounds in which the alkyl chain length is C16 to C22.
- Suitable cationic surfactants include quaternary ammonium compounds, particularly trimethyl quaternary compounds.
- Preferred quaternary ammonium compounds include cetyltrimethylammonium chloride, behenyltrimethylammonium chloride (BTAC), cetylpyridinium chloride, tetramethylammonium chloride, tetraethylammonium chloride, octyltrimethylammonium chloride, dodecyltrimethylammonium chloride, hexadecyltrimethylammonium chloride, octyldimethylbenzylammonium chloride, decyldimethylbenzylammonium chloride, stearyldimethylbenzylammonium chloride, didodecyldimethylammonium chloride, dioctadecyldimethylammonium chloride, tallowtrimethylammonium chloride, cocotrimethylammonium chloride, PEG-2 oleyl
- cationic surfactants include those materials having the CTFA designations Quaternium-5, Quaternium-31 and Quaternium-18. Mixtures of any of the foregoing materials may also be suitable.
- a particularly useful cationic surfactant for use in hair conditioners of the invention is cetyltrimethylammonium chloride, available commercially, for example as GENAMIN CTAC, ex Hoechst Celanese.
- Salts of primary, secondary, and tertiary fatty amines are also suitable cationic surfactants.
- the level of cationic surfactant is preferably from 0.01 to 10, more preferably 0.05 to 5, most preferably 0.1 to 2 % w/w of the total composition.
- Conditioner compositions of the invention preferably additionally comprise fatty materials.
- fatty material is meant a fatty alcohol, an alkoxylated fatty alcohol, a fatty acid, a glyceride, glycerol, plant unsaponifiables or a mixture thereof.
- Representative fatty alcohols comprise from 8 to 22 carbon atoms, more preferably 16 to 22.
- Fatty alcohols are typically compounds containing straight chain alkyl groups. Examples of suitable fatty alcohols include cetyl alcohol, stearyl alcohol and mixtures thereof. The use of these materials is also advantageous in that they contribute to the overall conditioning properties of the composition.
- Ethoxylated fatty alcohols having from about 12 to about 18 carbon atoms in the alkyl chain can be used in place of, or in addition to, the fatty alcohols themselves. Suitable examples include ethylene glycol cetyl ether, polyoxyethylene (2) stearyl ether, polyoxyethylene (4) cetyl ether, and mixtures thereof.
- the level of fatty alcohol material in conditioners of the invention is suitably from 0.01 to 15, preferably from 0.1 to 10, and more preferably from 0.1 to 5 % w/w.
- the weight ratio of cationic surfactant to fatty alcohol is suitably from 10:1 to 1 :10, preferably from 4:1 to 1 :8, optimally from 1 :1 to 1 :7, for example 1 :3.
- the hair care compositions especially if it is a shampoo, further comprises from 0.1 to 5 % w/w of a suspending agent.
- Suitable suspending agents are selected from polyacrylic acids, cross-linked polymers of acrylic acid, copolymers of acrylic acid with a hydrophobic monomer, copolymers of carboxylic acid-containing monomers and acrylic esters, cross-linked copolymers of acrylic acid and acrylate esters, heteropolysaccharide gums and crystalline long chain acyl derivatives, and mixtures thereof.
- the long chain acyl derivative is desirably selected from ethylene glycol stearate, alkanolamides of fatty acids having from 16 to 22 carbon atoms and mixtures thereof.
- Polyacrylic acid is available commercially as Carbopol 420, Carbopol 488 or Carbopol 493.
- Polymers of acrylic acid cross-linked with a polyfunctional agent may also be used; they are available commercially as Carbopol 910, Carbopol 934, Carbopol 941 and Carbopol 980.
- An example of a suitable copolymer of a carboxylic acid containing monomer and acrylic acid esters is Carbopol 1342. All Carbopol (trademark) materials are available from Goodrich.
- Suitable cross-linked polymers of acrylic acid and acrylate esters are Pemulen TR1 or Pemulen TR2 (both available from Lubrizol).
- a suitable heteropolysaccharide gum is xanthan gum. Silicone Conditioning Agents
- the hair care compositions of the invention can contain emulsified droplets of a silicone-conditioning agent for enhancing conditioning performance.
- Suitable silicones include polydiorganosiloxanes, in particular polydimethylsiloxanes which have the CTFA designation dimethicone.
- polydimethylsiloxanes which have the CTFA designation dimethicone.
- polydimethyl siloxanes having hydroxyl end groups which have the CTFA designation dimethiconol.
- silicone gums having a slight degree of cross-linking as are described for example in WO 96/31 188.
- Suitable pre-formed silicone emulsions include dimethiconol emulsions DC2-1766, DC2-1784, DC-1785, DC-1786 and DC-1788, all available from Dow Corning. Also suitable are amodimethicone emulsions such as DC2-8177 and DC939 (from Dow Corning) and SME253 (from GE Silicones).
- a further preferred class of silicones for inclusion in shampoos and conditioners of the invention have at least one amino functional group.
- the total amount of silicone is preferably from 0.01 to 10 of the total composition more preferably from 0.3 to 5, most preferably 0.5 to 3 % w/w is a suitable level .
- the hair care compositions according to the present invention may also comprise a dispersed, non-volatile, water-insoluble oily conditioning agent.
- insoluble is meant that the material is not soluble in water (distilled or equivalent) at a concentration of 0.1 % w/w at 25°C.
- Suitable oily or fatty materials are selected from hydrocarbon oils, fatty esters and mixtures thereof.
- the hair care compositions of the present invention may also contain adjuvants suitable for hair care. Generally such ingredients are included individually at a level of up to 2, preferably up to 1 % w/w of the total composition.
- Suitable hair care adjuvants include amino acids, sugars and ceramides. Particularly preferred are anti-dandruff agents, especially those comprising zinc, such as zinc pyrithione (ZnPTO). A further preferred ingredient is climbazole. Styling Polymers
- the hair styling polymer if present, is preferably present in the hair care compositions of the invention in an amount of from 0.001 to 10, more preferably from 0.1 to 10 by weight, such as from 1 to 8 % w/w.
- Hair styling polymers are well known. Suitable hair styling polymers include commercially available polymers that contain moieties that render the polymers cationic, anionic, amphoteric or nonionic in nature. Suitable hair styling polymers include, for example, block and graft copolymers. The polymers may be synthetic or naturally derived.
- Shampoo compositions preferably comprise one or more cleansing surfactants, which are cosmetically acceptable and suitable for topical application to the hair. Further surfactants may be present as emulsifiers.
- Suitable cleansing surfactants are selected from anionic, amphoteric and zwitterionic surfactants and mixtures thereof.
- the cleansing surfactant may be the same surfactant as the emulsifier, or may be different.
- Shampoo compositions according to the invention will typically comprise one or more anionic cleansing surfactants, which are cosmetically acceptable and suitable for topical application to the hair.
- anionic cleansing surfactants are the alkyl sulphates, alkyl ether sulphates, alkaryl sulphonates, alkanoyl isethionates, alkyl succinates, alkyl sulphosuccinates, N-alkyl sarcosinates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates and alpha-olefin sulphonates, especially their sodium, magnesium, ammonium and mono-, di- and triethanolamine salts.
- Typical anionic cleansing surfactants for use in shampoo compositions of the invention include sodium oleyl sulpho succinate, ammonium lauryl sulphosuccinate, ammonium lauryl sulphate, sodium cocoyl isethionate, sodium lauryl isethionate and sodium N-lauryl sarcosinate.
- the most preferred anionic surfactants are sodium lauryl sulphate, sodium lauryl ether sulphate (n)EO (where n ranges from 1 to 3), ammonium lauryl sulphate and ammonium lauryl ether sulphate (n)EO (where n ranges from 1 to 3).
- the total amount of anionic cleansing surfactant in shampoo compositions of the invention is generally from 5 to 30, preferably from 6 to 20, more preferably from 8 to 16 % w/w.
- the shampoo composition can optionally include co-surfactants, preferably an amphoteric or zwitterionic surfactant, which can be included in an amount ranging from 0 to about 8, preferably from 1 to 4 % w/w.
- co-surfactants preferably an amphoteric or zwitterionic surfactant, which can be included in an amount ranging from 0 to about 8, preferably from 1 to 4 % w/w.
- amphoteric and zwitterionic surfactants include, alkyl betaines, alkyl amidopropyl betaines, alkyl sulphobetaines (sultaines), alkyl glycinates, alkyl carboxyglycinates, alkyl amphopropionates, alkylamphoglycinates, alkyl amidopropyl hydroxysultaines, acyl taurates and acyl glutamates, wherein the alkyl and acyl groups have from 8 to 19 carbon atoms.
- Typical amphoteric and zwitterionic surfactants for use in shampoo compositions of the invention include lauryl amine oxide, cocodi methyl sulphopropyl betaine and preferably lauryl betaine, cocamidopropyl betaine and sodium cocamphopropionate.
- Another preferred co-surfactant is a nonionic surfactant, which can be included in an amount ranging from 0 to 8, preferably from 2 to 5 % w/w.
- APG alkyl polyglycosides
- an APG is one which comprises an alkyl group connected (optionally via a bridging group) to a block of one or more glycosyl groups.
- Preferred APGs are defined by the following formula:
- RO - (G)n wherein R is a branched or straight chain C5 to C20 alkyl or alkenyl group, G is a saccharide group and n is from 1 to 10.
- the shampoo composition can also optionally include one or more cationic co- surfactants included in an amount ranging from 0.01 to 10, more preferably from 0.05 to 5, most preferably from 0.05 to 2 % w/w.
- cationic co- surfactants included in an amount ranging from 0.01 to 10, more preferably from 0.05 to 5, most preferably from 0.05 to 2 % w/w.
- Useful cationic surfactants are described hereinbelow in relation to conditioner compositions.
- the total amount of surfactant (including any co-surfactant, and/or any emulsifier) in shampoo compositions of the invention is generally from 5 to 50, preferably from 5 to 30, more preferably from 10 to 25 % w/w.
- a cationic surfactant is a preferred ingredient in compositions of the invention for enhancing conditioning performance.
- Suitable cationic conditioning surfactants include cetyltrimethylammonium chloride, behenyltrimethylammonium chloride, cetylpyridinium chloride, tetramethylammonium chloride, tetraethylammonium chloride, octyltrimethylammonium chloride, dodecyltrimethylammonium chloride, hexadecyltrimethylammonium chloride, octyldimethylbenzylammonium chloride, decyldimethylbenzylammonium chloride, stearyldimethylbenzylammonium chloride, didodecyldimethylammonium chloride, dioctadecyldimethylammonium chloride, tallowtrimethylammonium chloride, dihydrogenated tallow dimethyl ammonium chloride (e.g., Arquad
- amidoamines useful herein include stearamido-propyldimethylamine, stearamidopropyldiethylamine, stearamidoethyldiethylamine, stearamidoethyldimethylamine, palmitamidopropyldimethylamine, palmitamidopropyldiethylamine, palmitamidoethyldiethylamine, palmitamidoethyldimethylamine, behenamidopropyldimethylamine, behenamidopropyldiethylmine, behenamidoethyldiethylamine, behenamidoethyldimethylamine, arachidamidopropyldimethylamine, arachidamidopropyldiethyl
- the acid may be any organic or mineral acid which is capable of protonating the amidoamine in the hair care composition thus forming a tertiary amine salt which is in effect is a non-permanent quaternary ammonium or pseudo-quaternary ammonium cationic surfactant.
- Suitable acids useful herein include hydrochloric acid, acetic acid, tartaric acid, fumaric acid, lactic acid, malic acid, succinic acid, and mixtures thereof.
- the acid is included in a sufficient amount to protonate all the amidoamine present.
- Cationic polymers are preferred ingredients for enhancing conditioning performance.
- Suitable cationic polymers may be homopolymers which are cationically substituted or may be formed from two or more types of monomers.
- the weight average (Mw) molecular weight of the polymers will generally be between 100 000 and 2 million daltons.
- Cationic polymer will generally be present in a shampoo composition at levels of from 0.01 to 5%, preferably from 0.05 to 1 %, more preferably from 0.08 to 0.5% w/w of the composition.
- Suitable cationic polymers include, for example, cationic polysaccharide polymers, copolymers of vinyl monomers having cationic amine or quaternary ammonium functionalities with water soluble spacer monomers such as (meth)acrylamide, alkyl and dialkyl (meth)acrylamides, alkyl (meth)acrylate, vinyl caprolactone and vinyl pyrrolidine.
- the alkyl and dialkyl substituted monomers preferably have C1 -C7 alkyl groups, more preferably C1 -3 alkyl groups.
- Other suitable spacers include vinyl esters, vinyl alcohol, maleic anhydride, propylene glycol and ethylene glycol.
- the cationic surfactant or polymer will generally be present in compositions of the invention at levels of from 0.01 to 5, preferably from 0.05 to 1 , more preferably from 0.08 to 0.5 % w/w.
- the combined use of fatty alcohols and cationic surfactants in conditioning compositions is believed to be especially advantageous, because this leads to the formation of a lamellar phase, in which the cationic surfactant is dispersed.
- the weight ratio of cationic surfactant to fatty alcohol is suitably from 1 :1 to 1 :10, preferably from 1 :1 .5 to 1 :8, optimally from 1 :2 to 1 :5. If the weight ratio of cationic surfactant to fatty alcohol is too high, this can lead to eye irritancy from the composition. If it is too low, it can make the hair feel squeaky for some consumers.
- a hair care compositions of the invention may contain other ingredients for enhancing performance and/or consumer acceptability.
- Such ingredients include fragrance, dyes and pigments, pH adjusting agents, pearlescers or opacifiers, viscosity modifiers, and preservatives or antimicrobials.
- Each of these ingredients will be present in an amount effective to accomplish its purpose.
- these optional ingredients are included individually at a level of up to 5% w/w of the composition.
- Hair care compositions according to the invention are produced using methods known to the person skilled in the art.
- Example 1 A hair growth solution composition according to the invention (% weight)
- Example 2 A hair growth lotion composition according to the invention
- Example 3 ln-vitro increase in fibroblast cell growth with malvidin
- the assay described hereinbelow looks at the effect of an active on potentiation of cell growth in a low nutrient environment, ie at the effects of the active on cell growth factors which are mitogenic, rather than on the identification of an active which itself is mitogenic.
- DMSO dimethylsulphoxide
- FCS foetal calf serum
- Fibroblast cells from the NIH3T3D4 cell line (European collection of animal cell cultures, Health Protection Agency Porton Down, England) were cultured in DMEM media in the absence of antibiotics. The cells were removed using 10 mL of 0.25 % w/w trypsin and 0.038 % w/v EDTA in Hank's medium for 5 minutes, 10 mL DMEM containing 10 % v/v FCS was added and the cells were spun down at 1000 rpm for 2 minutes. After removing the medium the cells were washed in 10 mL of DMEM containing 10 % v/v FCS and spun at 1000 rpm for 2 minutes.
- the cells were then resuspended in 10 mL of DMEM containing 10% v/v FCS and counted using a cell counting chamber.
- a suspension of cells containing 5000 cells per 100 ⁇ (50,000 cells per mL) was prepared and 100 ⁇ of the cell suspension was plated out into a 96 well plate. The cells were allowed to adhere overnight in an incubator at 37 degrees centigrade in an atmosphere of 5% v/v CO 2 in air.
- test solution containing 1 , 0.1 and 0.01 ig malvidin per mL DMSO/DMEM/FCS with or without 10 ⁇ glibenclamide (a potassium ion channel blocker) and 0.1 mM tetraethylammonium (TEA is a potassium ion channel blocker which directly binds to the channel) was added to each of eight wells. Fresh media containing malvidin was added every day for 5 days.
- Table 1 The effect of malvidin on fibroblast cell growth and potassium channel opening (the results represent the mean with the SD (standard deviation) for 8 replicates; malvidin only, and malvidin and inhibitor combinations that are significantly different from the controls as measured by the Students t-test are shown as * P ⁇ 0.05).
- malvidin is a potassium channel opener and this leads to fibroblast cell growth.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Cosmetics (AREA)
Abstract
One of the major hair concerns for both men and women is that of hair loss. For men the most obvious manifestation of this is male pattern baldness known as alopecia areata. However hair shedding resulting in hair thinning is also a concern for both men and women. Individuals suffering hair loss often experience psychological disadvantages, for example social phobia, anxiety, and depression, due to their change in appearance. This invention relates to a hair care or oral blood pressure lowering composition comprising malvidin or a derivative thereof. The invention also relates to a cosmetic method for increasing hair fibre diameter, stimulating hair growth, retaining hair or reducing hair loss, stimulating hair follicle growth in anagen or telogen phases, increasing hair fibre density and preventing or treating alopecia.
Description
MALVIDIN FOR PROMOTING HAIR GROWTH
This invention relates to a hair care composition comprising malvidin or a derivative thereof. The invention also relates to a cosmetic method for increasing hair fibre diameter, stimulating hair growth, retaining hair or reducing hair loss, stimulating hair follicle growth in anagen or telogen phases, increasing hair fibre density and preventing or treating alopecia. One of the major hair concerns for both men and women is that of hair loss. For men the most obvious manifestation of this is male pattern baldness known as alopecia areata. However hair shedding resulting in hair thinning is also a concern for both men and women. Individuals suffering hair loss often experience psychological disadvantages, for example social phobia, anxiety, and depression, due to their change in appearance.
Various attempts have been made to combat these problems. For example stress reduction can be helpful in slowing hair loss (as stress can often be linked to periods of hair loss). A number of drugs, operating in quite different ways, have been used extensively. For example immunosuppressants applied to the scalp have been shown to temporarily reverse alopecia areata although there can be significant side effects from this treatment. Use of dihydrotestosterone inhibitors such as finasteride (in the form of an oral intervention) has been approved and 5-alpha reductase inhibitors such as ketoconazole have also been recommended. Other drugs include potassium channel opening and vasodilator compounds such as minoxidil (in the form of a 2 % w/w topical solution) and diazoxide.
Minoxidil was originally produced as an oral anti-hypertensive drug (Loniten™), which was found to also have hypertrichosis effects. Messenger et al (Br. J. Dermatol., 150/2, 186-194 (2004)), showed in clinical trials that topical minoxidil increases hair growth and diameter, triggering anagen induction and prolonging length of anagen and hence hair. In terms of the mode-of-action, Sanders et al (J.
Invest. Dermatol., 107/2, 229-234 (1996)) have shown that minoxidil is able to increase cell proliferation in NIH 3T3 fibroblasts via the opening of potassium channels. Messenger et al showed that other potassium channel openers exhibit a similar hypertrichosis effect. Lachgar et al (Br. J. Dermatol., 138/3,407-41 1 (1998)) has shown that minoxidil increases the vascular endothelial growth factor (VEGF) which plays an important role in hair growth angiogenesis and follicle cycling. In dermal papilla cells, Li et al (J. Invest Dermatol., 1 17/ 6, 1594-1600 (2001 )) has shown that minoxidil binds to the sulphonylurea receptor SUR2B component of KATP channels resulting in the secretion of ATP which is converted to adenosine and results in an increase VEGF levels.
The side effects of minoxidil include itchy scalp and dandruff, often due to the alcohol required for its topical formulation. Side effects of oral minoxidil include swelling of the face and extremities, rapid and irregular heartbeat, lightheadedness and cardiac lesions. Herbal treatments with saw palmetto and green tea extracts (both of which comprise 5-alpha reductase inhibitors), and Gingko biloba extract (which comprises an active vasodilator) have been used. Non-invasive treatments include scalp massage with essential oils. Caffeine has also been identified as a stimulator of human hair growth in-vitro, and reduced testosterone-induced follicle growth suppression.
An in-vitro screening assay to identify potassium channel openers through measuring cell mitogenesis in low serum conditions, in the absence of aminoglycoside antibiotics has been described previously in EP 0 842 427 which confirms the involvement of the potassium channel in the mitogenic effects via the use of multiple potassium channel blockers, more specifically KATP specific antagonists, such as tolbutamide or glibenclamide, in combination with weak nonselective potassium channel pore blockers such as tetraethylammonium (TEA). Summary of the invention
In a first aspect of the invention a solution to the aforementioned problem of hair loss is provided in the form of a hair care composition comprising malvidin or a derivative
thereof in a composition form selected from the group consisting of a shampoo, a conditioner, a spray, a mousse, a gel, an oil, a cream, a wax and a lotion.
Malvidin is an O-methylated anthocyanidin of empirical chemical formula C17H15O7+ highly abundant in nature. It is primarily responsible for the color of red wine, Vitis vinifera being one of its sources. It is also one of the anthocyanidins responsible for the blue pigment found in the Primula polyanthus plant. The lUPAC name for malvidin is 3,5,7-trihydroxy-2-(4-hydroxy- 3,5-dimethoxyphenyl)chromenium and has the following chemical structure:
OH
The malvidin or a derivative thereof may be in the form of an aqueous extract of any one of the group consisting of a Vitis vinifera grape skin, a Primula polyanthus flower and a Malva sylvestris flower. Preferably the malvidin or a derivative thereof is in the weight range 0.00001 to 30 %, preferably 0.0001 to 15 %, most preferably 0.001 to 5 % by weight of the composition.
Derivatives include glycosides such as glucosides or galactosides, acyl and malonyl derivatives. Specific derivatives are malvin, a diglucoside of malvidin, oenin, a 3- glucoside of malvidin found in the skin of purple grapes, and primulin, a 3- galactoside of malvidin. Malvin is found as a pigment in herbs like Malva (Malva sylvestris), Primula and Rhodoendron. It can be found in a variety of common foods, including but no limited to the following: radish, tomato, turnip, potato, pimento, black eyed pea, green pea, olive (green and black), onion, eggplant, cabbage, carrot, beet, avocadeo, corn, walnut, cashew, paprika, mustard seed, cinnamon, watermelon, rhubarb, strawberry, quince, peach, pear, plum, fig, grape (red and
green), apple, apricot, bananna, blackberry, blueberry, boysenberry, cheery, cranberry, black currents, crabmeat, albumin (cow's milk), cheese, yoghurt, butter, sugar beet and honey. In a second aspect of the invention, a hair care composition comprising malvidin or a derivative thereof and an ingredient selected from the group consisting of a cationic surfactant, a fatty material, a suspending agent, a silicone, an anti-dandruff agent, an anionic surfactant, an amphoteric surfactant, a zwitlerionic surfactant and a fragrance.
In a third aspect of the invention, a cosmetic method for stimulating hair growth is provided, the method comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
In a fourth aspect of the invention, a cosmetic method for increasing hair fibre density is provided, the method comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
In a fifth aspect of the invention, a cosmetic method for increasing hair fibre diameter, the method comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
In a sixth aspect of the invention, a cosmetic method for retaining hair or reducing hair loss is provided, the method the step of comprising applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
In a seventh aspect of the invention, a cosmetic method for preventing or treating alopecia is provided, the method comprising the step of applying the hair care
composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
In a eighth aspect of the invention, a cosmetic method for stimulating anagen induction is provided, the method comprising the step of applying the hair care composition of the first or second aspects of the invention to a scalp or hair of a person in need thereof.
Detailed description of the invention
The final product form of the hair care compositions according to the invention may suitably be, for example, shampoos, conditioners, sprays, mousses, gels, oils, creams, waxes or lotions. Particularly preferred product forms are leave-in products, especially post-wash conditioners (leave-in) and hair treatment products such as hair essences.
Conditioning Surfactant
Conditioner compositions usually comprise one or more conditioning surfactants, which are cosmetically acceptable and suitable for topical application to the hair. Suitable conditioning surfactants are selected from cationic surfactants, used singly or in a mixture.
Cationic surfactants useful in compositions of the invention contain amino or quaternary ammonium hydrophilic moieties, which are positively charged when, dissolved in the aqueous composition of the present invention.
The most preferred cationic surfactants for conditioner compositions of the present invention are monoalkyl quaternary ammonium compounds in which the alkyl chain length is C16 to C22.
Examples of suitable cationic surfactants include quaternary ammonium compounds, particularly trimethyl quaternary compounds.
Preferred quaternary ammonium compounds include cetyltrimethylammonium chloride, behenyltrimethylammonium chloride (BTAC), cetylpyridinium chloride, tetramethylammonium chloride, tetraethylammonium chloride, octyltrimethylammonium chloride, dodecyltrimethylammonium chloride, hexadecyltrimethylammonium chloride, octyldimethylbenzylammonium chloride, decyldimethylbenzylammonium chloride, stearyldimethylbenzylammonium chloride, didodecyldimethylammonium chloride, dioctadecyldimethylammonium chloride, tallowtrimethylammonium chloride, cocotrimethylammonium chloride, PEG-2 oleylammonium chloride and salts of these where the chloride is replaced by halogen, (e.g. , bromide), acetate, citrate, lactate, glycolate, phosphate nitrate, sulphate, or alkylsulphate. Further suitable cationic surfactants include those materials having the CTFA designations Quaternium-5, Quaternium-31 and Quaternium-18. Mixtures of any of the foregoing materials may also be suitable. A particularly useful cationic surfactant for use in hair conditioners of the invention is cetyltrimethylammonium chloride, available commercially, for example as GENAMIN CTAC, ex Hoechst Celanese.
Salts of primary, secondary, and tertiary fatty amines are also suitable cationic surfactants.
In the conditioners of the invention, the level of cationic surfactant is preferably from 0.01 to 10, more preferably 0.05 to 5, most preferably 0.1 to 2 % w/w of the total composition. Fatty Materials
Conditioner compositions of the invention preferably additionally comprise fatty materials. By "fatty material" is meant a fatty alcohol, an alkoxylated fatty alcohol, a fatty acid, a glyceride, glycerol, plant unsaponifiables or a mixture thereof. Representative fatty alcohols comprise from 8 to 22 carbon atoms, more preferably 16 to 22. Fatty alcohols are typically compounds containing straight chain alkyl groups. Examples of suitable fatty alcohols include cetyl alcohol, stearyl alcohol and
mixtures thereof. The use of these materials is also advantageous in that they contribute to the overall conditioning properties of the composition.
Ethoxylated fatty alcohols having from about 12 to about 18 carbon atoms in the alkyl chain can be used in place of, or in addition to, the fatty alcohols themselves. Suitable examples include ethylene glycol cetyl ether, polyoxyethylene (2) stearyl ether, polyoxyethylene (4) cetyl ether, and mixtures thereof.
The level of fatty alcohol material in conditioners of the invention is suitably from 0.01 to 15, preferably from 0.1 to 10, and more preferably from 0.1 to 5 % w/w. The weight ratio of cationic surfactant to fatty alcohol is suitably from 10:1 to 1 :10, preferably from 4:1 to 1 :8, optimally from 1 :1 to 1 :7, for example 1 :3.
Suspending Agents
In a preferred embodiment, the hair care compositions, especially if it is a shampoo, further comprises from 0.1 to 5 % w/w of a suspending agent.
Suitable suspending agents are selected from polyacrylic acids, cross-linked polymers of acrylic acid, copolymers of acrylic acid with a hydrophobic monomer, copolymers of carboxylic acid-containing monomers and acrylic esters, cross-linked copolymers of acrylic acid and acrylate esters, heteropolysaccharide gums and crystalline long chain acyl derivatives, and mixtures thereof. The long chain acyl derivative is desirably selected from ethylene glycol stearate, alkanolamides of fatty acids having from 16 to 22 carbon atoms and mixtures thereof. Polyacrylic acid is available commercially as Carbopol 420, Carbopol 488 or Carbopol 493. Polymers of acrylic acid cross-linked with a polyfunctional agent may also be used; they are available commercially as Carbopol 910, Carbopol 934, Carbopol 941 and Carbopol 980. An example of a suitable copolymer of a carboxylic acid containing monomer and acrylic acid esters is Carbopol 1342. All Carbopol (trademark) materials are available from Goodrich. Suitable cross-linked polymers of acrylic acid and acrylate esters are Pemulen TR1 or Pemulen TR2 (both available from Lubrizol). A suitable heteropolysaccharide gum is xanthan gum.
Silicone Conditioning Agents
The hair care compositions of the invention can contain emulsified droplets of a silicone-conditioning agent for enhancing conditioning performance. Suitable silicones include polydiorganosiloxanes, in particular polydimethylsiloxanes which have the CTFA designation dimethicone. Also suitable for use compositions of the invention (particularly shampoos and conditioners) are polydimethyl siloxanes having hydroxyl end groups, which have the CTFA designation dimethiconol. Also suitable for use in compositions of the invention are silicone gums having a slight degree of cross-linking, as are described for example in WO 96/31 188.
Examples of suitable pre-formed silicone emulsions include dimethiconol emulsions DC2-1766, DC2-1784, DC-1785, DC-1786 and DC-1788, all available from Dow Corning. Also suitable are amodimethicone emulsions such as DC2-8177 and DC939 (from Dow Corning) and SME253 (from GE Silicones).
A further preferred class of silicones for inclusion in shampoos and conditioners of the invention have at least one amino functional group. The total amount of silicone is preferably from 0.01 to 10 of the total composition more preferably from 0.3 to 5, most preferably 0.5 to 3 % w/w is a suitable level .
Non-silicone Oily Conditioning Components
The hair care compositions according to the present invention may also comprise a dispersed, non-volatile, water-insoluble oily conditioning agent.
By "insoluble" is meant that the material is not soluble in water (distilled or equivalent) at a concentration of 0.1 % w/w at 25°C. Suitable oily or fatty materials are selected from hydrocarbon oils, fatty esters and mixtures thereof.
Adjuvants
The hair care compositions of the present invention may also contain adjuvants suitable for hair care. Generally such ingredients are included individually at a level of up to 2, preferably up to 1 % w/w of the total composition.
Suitable hair care adjuvants, include amino acids, sugars and ceramides. Particularly preferred are anti-dandruff agents, especially those comprising zinc, such as zinc pyrithione (ZnPTO). A further preferred ingredient is climbazole. Styling Polymers
The hair styling polymer, if present, is preferably present in the hair care compositions of the invention in an amount of from 0.001 to 10, more preferably from 0.1 to 10 by weight, such as from 1 to 8 % w/w. Hair styling polymers are well known. Suitable hair styling polymers include commercially available polymers that contain moieties that render the polymers cationic, anionic, amphoteric or nonionic in nature. Suitable hair styling polymers include, for example, block and graft copolymers. The polymers may be synthetic or naturally derived.
Surfactants
Shampoo compositions preferably comprise one or more cleansing surfactants, which are cosmetically acceptable and suitable for topical application to the hair. Further surfactants may be present as emulsifiers.
Suitable cleansing surfactants are selected from anionic, amphoteric and zwitterionic surfactants and mixtures thereof. The cleansing surfactant may be the same surfactant as the emulsifier, or may be different. Anionic Cleansing Surfactant
Shampoo compositions according to the invention will typically comprise one or more anionic cleansing surfactants, which are cosmetically acceptable and suitable for
topical application to the hair.
Examples of suitable anionic cleansing surfactants are the alkyl sulphates, alkyl ether sulphates, alkaryl sulphonates, alkanoyl isethionates, alkyl succinates, alkyl sulphosuccinates, N-alkyl sarcosinates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates and alpha-olefin sulphonates, especially their sodium, magnesium, ammonium and mono-, di- and triethanolamine salts.
Typical anionic cleansing surfactants for use in shampoo compositions of the invention include sodium oleyl sulpho succinate, ammonium lauryl sulphosuccinate, ammonium lauryl sulphate, sodium cocoyl isethionate, sodium lauryl isethionate and sodium N-lauryl sarcosinate. The most preferred anionic surfactants are sodium lauryl sulphate, sodium lauryl ether sulphate (n)EO (where n ranges from 1 to 3), ammonium lauryl sulphate and ammonium lauryl ether sulphate (n)EO (where n ranges from 1 to 3).
The total amount of anionic cleansing surfactant in shampoo compositions of the invention is generally from 5 to 30, preferably from 6 to 20, more preferably from 8 to 16 % w/w.
Co-surfactant
The shampoo composition can optionally include co-surfactants, preferably an amphoteric or zwitterionic surfactant, which can be included in an amount ranging from 0 to about 8, preferably from 1 to 4 % w/w.
Examples of amphoteric and zwitterionic surfactants include, alkyl betaines, alkyl amidopropyl betaines, alkyl sulphobetaines (sultaines), alkyl glycinates, alkyl carboxyglycinates, alkyl amphopropionates, alkylamphoglycinates, alkyl amidopropyl hydroxysultaines, acyl taurates and acyl glutamates, wherein the alkyl and acyl groups have from 8 to 19 carbon atoms. Typical amphoteric and zwitterionic surfactants for use in shampoo compositions of the invention include lauryl amine
oxide, cocodi methyl sulphopropyl betaine and preferably lauryl betaine, cocamidopropyl betaine and sodium cocamphopropionate.
Another preferred co-surfactant is a nonionic surfactant, which can be included in an amount ranging from 0 to 8, preferably from 2 to 5 % w/w.
For example, representative nonionic surfactants that can be included in shampoo compositions of the invention include condensation products of aliphatic (C8 - C18) primary or secondary linear or branched chain alcohols or phenols with alkylene oxides, usually ethylene oxide and generally having from 6 to 30 ethylene oxide groups.
Further nonionic surfactants which can be included in shampoo compositions of the invention are the alkyl polyglycosides (APGs). Typically, an APG is one which comprises an alkyl group connected (optionally via a bridging group) to a block of one or more glycosyl groups. Preferred APGs are defined by the following formula:
RO - (G)n wherein R is a branched or straight chain C5 to C20 alkyl or alkenyl group, G is a saccharide group and n is from 1 to 10.
The shampoo composition can also optionally include one or more cationic co- surfactants included in an amount ranging from 0.01 to 10, more preferably from 0.05 to 5, most preferably from 0.05 to 2 % w/w. Useful cationic surfactants are described hereinbelow in relation to conditioner compositions.
The total amount of surfactant (including any co-surfactant, and/or any emulsifier) in shampoo compositions of the invention is generally from 5 to 50, preferably from 5 to 30, more preferably from 10 to 25 % w/w.
Cationic Surfactant or Polymer
A cationic surfactant is a preferred ingredient in compositions of the invention for enhancing conditioning performance. Suitable cationic conditioning surfactants include cetyltrimethylammonium chloride, behenyltrimethylammonium chloride, cetylpyridinium chloride, tetramethylammonium chloride, tetraethylammonium chloride, octyltrimethylammonium chloride, dodecyltrimethylammonium chloride, hexadecyltrimethylammonium chloride, octyldimethylbenzylammonium chloride, decyldimethylbenzylammonium chloride, stearyldimethylbenzylammonium chloride, didodecyldimethylammonium chloride, dioctadecyldimethylammonium chloride, tallowtrimethylammonium chloride, dihydrogenated tallow dimethyl ammonium chloride (e.g., Arquad 2HT/75 from Akzo Nobel), cocotrimethylammonium chloride, PEG-2-oleammonium chloride and the corresponding hydroxides thereof, Quaternium-5, Quaternium-31 , Quaternium-18 and mixtures thereof.
Another example of a class of suitable cationic conditioning surfactants either alone or in admixture with one or more other cationic conditioning surfactants, is a combination of an amidoamine and an acid. Preferred amidoamines useful herein include stearamido-propyldimethylamine, stearamidopropyldiethylamine, stearamidoethyldiethylamine, stearamidoethyldimethylamine, palmitamidopropyldimethylamine, palmitamidopropyldiethylamine, palmitamidoethyldiethylamine, palmitamidoethyldimethylamine, behenamidopropyldimethylamine, behenamidopropyldiethylmine, behenamidoethyldiethylamine, behenamidoethyldimethylamine, arachidamidopropyldimethylamine, arachidamidopropyldiethylamine, arachid- amidoethyldiethylamine, arachidamidoethyldimethylamine, and mixtures thereof. The acid may be any organic or mineral acid which is capable of protonating the amidoamine in the hair care composition thus forming a tertiary amine salt which is in effect is a non-permanent quaternary ammonium or pseudo-quaternary ammonium cationic surfactant. Suitable acids useful herein include hydrochloric acid, acetic acid, tartaric acid, fumaric acid, lactic acid, malic acid, succinic acid, and
mixtures thereof. Suitably, the acid is included in a sufficient amount to protonate all the amidoamine present.
Cationic polymers are preferred ingredients for enhancing conditioning performance. Suitable cationic polymers may be homopolymers which are cationically substituted or may be formed from two or more types of monomers. The weight average (Mw) molecular weight of the polymers will generally be between 100 000 and 2 million daltons. Cationic polymer will generally be present in a shampoo composition at levels of from 0.01 to 5%, preferably from 0.05 to 1 %, more preferably from 0.08 to 0.5% w/w of the composition. Suitable cationic polymers include, for example, cationic polysaccharide polymers, copolymers of vinyl monomers having cationic amine or quaternary ammonium functionalities with water soluble spacer monomers such as (meth)acrylamide, alkyl and dialkyl (meth)acrylamides, alkyl (meth)acrylate, vinyl caprolactone and vinyl pyrrolidine. The alkyl and dialkyl substituted monomers preferably have C1 -C7 alkyl groups, more preferably C1 -3 alkyl groups. Other suitable spacers include vinyl esters, vinyl alcohol, maleic anhydride, propylene glycol and ethylene glycol.
The cationic surfactant or polymer will generally be present in compositions of the invention at levels of from 0.01 to 5, preferably from 0.05 to 1 , more preferably from 0.08 to 0.5 % w/w. The combined use of fatty alcohols and cationic surfactants in conditioning compositions is believed to be especially advantageous, because this leads to the formation of a lamellar phase, in which the cationic surfactant is dispersed. The weight ratio of cationic surfactant to fatty alcohol is suitably from 1 :1 to 1 :10, preferably from 1 :1 .5 to 1 :8, optimally from 1 :2 to 1 :5. If the weight ratio of cationic surfactant to fatty alcohol is too high, this can lead to eye irritancy from the composition. If it is too low, it can make the hair feel squeaky for some consumers.
Optional Ingredients
A hair care compositions of the invention may contain other ingredients for enhancing performance and/or consumer acceptability. Such ingredients include fragrance, dyes and pigments, pH adjusting agents, pearlescers or opacifiers,
viscosity modifiers, and preservatives or antimicrobials. Each of these ingredients will be present in an amount effective to accomplish its purpose. Generally these optional ingredients are included individually at a level of up to 5% w/w of the composition.
Hair care compositions according to the invention are produced using methods known to the person skilled in the art.
Example 1 : A hair growth solution composition according to the invention (% weight)
Example 2: A hair growth lotion composition according to the invention
(% weight)
Name Trade Name Function %
Dl Water Deionized water Initial charge (1 ) 55
Methylparaben Nipagin M Preservative 0.3
Behentrimonium chloride Genammin BTLF Hair conditioner agent, 0.31
(70%) anti-static agent
Cetearyl alcohol Hydrenol MY Emulsifying agent 0.5
Isopropyl myristate IPM, Estol 1514 Conditioning agent 2
Glabranin 0.1
Glycerin USP Glycerin 99.7% Humectant 1
Dl Water Deionized water Flush water (2) 0.1
Perfume 0.4
Dl Water Deionized water Quench water (3) To 100
Cyclopentasiloxane 99% DC(R) 245 Fluid Conditioning agent 0.5
DMDM Hydantoin Glydant, Nipaguard Preservative 0.2
DMDMH
Polyquat 37 Salcare SC96 Viscosity modifier 0.9
Example 3: ln-vitro increase in fibroblast cell growth with malvidin
The assay described hereinbelow looks at the effect of an active on potentiation of cell growth in a low nutrient environment, ie at the effects of the active on cell growth factors which are mitogenic, rather than on the identification of an active which itself is mitogenic.
Malvidin chloride (Fischer Scientific) was added in 50 μΙ_ of dimethylsulphoxide (DMSO) and vortexed to dissolve. 5 ml_ of the malvidin in DMSO was added to Dulbeccos Minimum Essential Medium (DMEM) containing 2 % v/v foetal calf serum (FCS) to give a 10 pg/nriL malvidin solution. Serial dilutions were prepared using DMSO/DMEM/FCS as above. 1 mM minoxidil in DMSO/DMEM/FCS as above was used as a positive control. A DMSO control in DMEM containing 2 % v/v FCS was also prepared.
Fibroblast cells from the NIH3T3D4 cell line (European collection of animal cell cultures, Health Protection Agency Porton Down, England) were cultured in DMEM media in the absence of antibiotics. The cells were removed using 10 mL of 0.25 % w/w trypsin and 0.038 % w/v EDTA in Hank's medium for 5 minutes, 10 mL DMEM containing 10 % v/v FCS was added and the cells were spun down at 1000 rpm for 2 minutes. After removing the medium the cells were washed in 10 mL of DMEM containing 10 % v/v FCS and spun at 1000 rpm for 2 minutes. The cells were then resuspended in 10 mL of DMEM containing 10% v/v FCS and counted using a cell counting chamber. A suspension of cells containing 5000 cells per 100 μί (50,000 cells per mL) was prepared and 100 μί of the cell suspension was plated out into a 96 well plate. The cells were allowed to adhere overnight in an incubator at 37 degrees centigrade in an atmosphere of 5% v/v CO2 in air. After washing the wells thrice with DMEM (without FCS), 100 μί of the test solution (containing 1 , 0.1 and
0.01 ig malvidin per mL DMSO/DMEM/FCS with or without 10 μΜ glibenclamide (a potassium ion channel blocker) and 0.1 mM tetraethylammonium (TEA is a potassium ion channel blocker which directly binds to the channel) was added to each of eight wells. Fresh media containing malvidin was added every day for 5 days.
Cell numbers were determined after 5 days in test medium using a colourimetric method (Promega CellTiter Reagent from Promega). 20 μΙ_ Reagent was added to each well and the plate incubated as before for one hour. The absorbance was read at 450 nm and the results are shown in table 1 .
Table 1 : The effect of malvidin on fibroblast cell growth and potassium channel opening (the results represent the mean with the SD (standard deviation) for 8 replicates; malvidin only, and malvidin and inhibitor combinations that are significantly different from the controls as measured by the Students t-test are shown as * P<0.05).
From table 1 , it is apparent that malvidin is a potassium channel opener and this leads to fibroblast cell growth.
Claims
1 . A hair care composition comprising malvidin or a derivative thereof in a composition form selected from the group consisting of a shampoo, a conditioner, a spray, a mousse, a gel, an oil, a cream, a wax and a lotion.
2. A hair care composition comprising malvidin or a derivative thereof and an ingredient selected from the group consisting of a cationic surfactant, a fatty material, a suspending agent, a silicone, an anti-dandruff agent, an anionic surfactant, an amphoteric surfactant, a zwitlerionic surfactant and a fragrance.
3. A hair care composition according to claim 1 or claim 2 wherein the malvidin or a derivative thereof is in the form of an aqueous extract of any one of the group consisting of a Vitis vinifera grape skin, a Primula polyanthus flower and a Malva sylvestris flower.
4. A hair care composition according to any one of the preceding claims, wherein the malvidin or a derivative thereof is in the weight range 0.00001 to 30 %, preferably 0.0001 to 15 %, most preferably 0.001 to 5 % by weight of the composition.
5. A hair care composition according to any one of the preceding claims, wherein the hair care composition additionally comprises a further hair growth active.
6. A cosmetic method for stimulating hair growth, the method comprising the step of applying malvidin or a derivative thereof or the hair care composition according to any one of claims 1 to 5 to a scalp or hair.
7. A cosmetic method for increasing hair fibre density, the method comprising the step of applying malvidin or a derivative thereof or the hair care composition according to any one of claims 1 to 5 to a scalp or hair. A cosmetic method for increasing hair fibre diameter, the method comprising the step of applying malvidin or a derivative thereof or the hair care composition according to any one of claims 1 to 5 to a scalp or hair.
A cosmetic method for retaining hair or reducing hair loss, the method the step of comprising applying malvidin or a derivative thereof or the hair care composition according to any one of claims 1 to 5 to a scalp or hair.
A cosmetic method for preventing or treating alopecia, the method comprising the step of applying malvidin or a derivative thereof or the hair care composition according to any one of claims 1 to 5 to a scalp or hair.
A cosmetic method for stimulating anagen induction, the method comprising the step of applying malvidin or a derivative thereof or the hair care composition according to any one of claims 1 to 5 to a scalp or hair.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11728886.0A EP2590623A1 (en) | 2010-07-06 | 2011-07-04 | Malvidin for promoting hair growth |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10168506 | 2010-07-06 | ||
| EP11728886.0A EP2590623A1 (en) | 2010-07-06 | 2011-07-04 | Malvidin for promoting hair growth |
| PCT/EP2011/061242 WO2012004227A1 (en) | 2010-07-06 | 2011-07-04 | Malvidin for promoting hair growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2590623A1 true EP2590623A1 (en) | 2013-05-15 |
Family
ID=42556499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP11728886.0A Withdrawn EP2590623A1 (en) | 2010-07-06 | 2011-07-04 | Malvidin for promoting hair growth |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2590623A1 (en) |
| JP (1) | JP2013529670A (en) |
| CN (1) | CN103002871A (en) |
| BR (1) | BR112012031680A2 (en) |
| WO (1) | WO2012004227A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013234140A (en) * | 2012-05-08 | 2013-11-21 | Oriza Yuka Kk | Trichogenous agent |
| CN104337998A (en) * | 2013-07-25 | 2015-02-11 | 张琦 | Alopecia stopping and hair growth agent of nature plant composite extracts, and preparation method thereof |
| JP2022091014A (en) * | 2020-12-08 | 2022-06-20 | 日本ゼオン株式会社 | Use as a medium for culturing animal cells, a method for culturing animal cells, a cell death inhibitor for cultured animal cells, and a cell death inhibitor for cultured animal cells. |
| JP2022124930A (en) * | 2021-02-16 | 2022-08-26 | 株式会社ファンケル | External skin preparation, anti-wrinkle agent, and collagen production promoter |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU208256B (en) * | 1991-12-12 | 1993-09-28 | Mate Hidvegi | Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood |
| GB9507130D0 (en) | 1995-04-06 | 1995-05-31 | Unilever Plc | Hair treatment composition |
| GB9520411D0 (en) | 1995-10-06 | 1995-12-06 | Wales College Of Medicine | Method of testing |
| FR2809003B1 (en) * | 2000-05-18 | 2003-01-24 | Oreal | ANTI-POLLUTION COMPOSITIONS BASED ON ANTHOCYANES |
| JP3309221B1 (en) * | 2001-04-27 | 2002-07-29 | 株式会社コスモビューティー | Hair dyeing hair styling composition |
| FR2834986B1 (en) * | 2002-01-22 | 2004-02-20 | Oreal | NOVEL CERAMIDES, COMPOSITIONS CONTAINING THEM AND THEIR COSMETIC OR DERMATOLOGICAL USE |
| EP2135512B1 (en) * | 2008-06-19 | 2010-06-16 | Ali Dr. Muin | Compound based on malic acid, caffeic acid, a flavan-3-ol and an anthocyane and its use in food and medicine |
| GB0908397D0 (en) * | 2009-05-15 | 2009-06-24 | Univ Leeds | Natural hair dyes |
-
2011
- 2011-07-04 WO PCT/EP2011/061242 patent/WO2012004227A1/en not_active Ceased
- 2011-07-04 EP EP11728886.0A patent/EP2590623A1/en not_active Withdrawn
- 2011-07-04 BR BR112012031680A patent/BR112012031680A2/en not_active IP Right Cessation
- 2011-07-04 JP JP2013517341A patent/JP2013529670A/en not_active Withdrawn
- 2011-07-04 CN CN2011800330542A patent/CN103002871A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2012004227A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013529670A (en) | 2013-07-22 |
| CN103002871A (en) | 2013-03-27 |
| BR112012031680A2 (en) | 2016-08-23 |
| WO2012004227A1 (en) | 2012-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009053431A2 (en) | Hair care composition | |
| CA2707544A1 (en) | Personal care composition | |
| KR20050050142A (en) | Scalp treatment | |
| EP3496819B1 (en) | Hair treatment composition | |
| EP2590623A1 (en) | Malvidin for promoting hair growth | |
| US20130096189A1 (en) | Use of glabranin for stimulating hair growth | |
| EP1893173B1 (en) | Amino-oxo-indole-ylidene compounds for use in treating scalp skin itching | |
| EP1915198B1 (en) | Visnadin for treating scalp skin itching | |
| EP2683446B1 (en) | Hair care composition comprising pyrithione and a pearliser system based on bismuth oxychloride | |
| EP1893289A1 (en) | Hair and/or scalp care compositions incorporating amino-oxo-indole-ylidene compounds | |
| US8298553B2 (en) | Personal care composition | |
| EP2099423B1 (en) | Method of hair treatment | |
| US20100094053A1 (en) | Use of personal care composition | |
| EP2246034A2 (en) | Use of personal care composition | |
| EP4400091A1 (en) | Compositions comprising myricitrin for treating signs of aging | |
| EP4480471A1 (en) | Specific compounds for treating signs of skin aging and/or hair aging | |
| EP4400093A1 (en) | Compositions comprising epilobium fleischeri extract for treating signs of aging | |
| EP2683445A2 (en) | Hair care composition comprising pyrithione and a purple, pink or red colouring component |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20121119 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20140214 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20140617 |